Effectiveness of an NK1 Antagonist in Decreasing Symptoms of Post-Traumatic Stress Disorder - Contacts and Locations

Effectiveness of an NK1 Antagonist in Decreasing Symptoms of Post-Traumatic Stress Disorder

This study is currently recruiting participants.

Study NCT00211861. Last updated on September 17, 2008. Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00211861

Contacts


Contact: Douglas Brodman		douglas.brodman@mssm.edu

Locations


United States, New York
	Mount Sinai School of Medicine	Recruiting
	New York, New York, United States, 10029-6574
	Contact: Douglas Brodman 212-241-6603 douglas.brodman@mssm.edu
	Principal Investigator: Dennis Charney, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Dennis Charney, MD	Mount Sinai School of Medicine